Report for Pryor KA

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1 - Migoya_2010_Clin.Pharmacol.Ther_88_801
Author(s) : Migoya EM , Bergeron R , Miller JL , Snyder RN , Tanen M , Hilliard D , Weiss B , Larson P , Gutierrez M , Jiang G , Liu F , Pryor KA , Yao J , Zhu L , Holst JJ , Deacon C , Herman G , Thornberry N , Amatruda J , Williams-Herman D , Wagner JA , SinhaRoy R
Ref : Clinical Pharmacology & Therapeutics , 88 :801 , 2010
Abstract : Migoya_2010_Clin.Pharmacol.Ther_88_801
ESTHER : Migoya_2010_Clin.Pharmacol.Ther_88_801
PubMedSearch : Migoya_2010_Clin.Pharmacol.Ther_88_801
PubMedID: 21048706

Title : Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9 - Lankas_2005_Diabetes_54_2988
Author(s) : Lankas GR , Leiting B , Roy RS , Eiermann GJ , Beconi MG , Biftu T , Chan CC , Edmondson S , Feeney WP , He H , Ippolito DE , Kim D , Lyons KA , Ok HO , Patel RA , Petrov AN , Pryor KA , Qian X , Reigle L , Woods A , Wu JK , Zaller D , Zhang X , Zhu L , Weber AE , Thornberry NA
Ref : Diabetes , 54 :2988 , 2005
Abstract : Lankas_2005_Diabetes_54_2988
ESTHER : Lankas_2005_Diabetes_54_2988
PubMedSearch : Lankas_2005_Diabetes_54_2988
PubMedID: 16186403